[CMV screening with the latex agglutination test in blood donors. Comparison between EIA and latex agglutination].
For CMV-Screening of blood donors the latex agglutination test (LAT) can be used as a complementary rapid analysis to the enzyme linked immunosorbent assay (EIA). In 98.56% there was no discrepancy between LAT and EIA in the serum, in 1.44% there was a negative LAT and a positive EIA.
Müller
R
R
Blutbank-Immunhämatologie-Transfusionsmedizin, Medizinische Hochschule Hannover.
Milbradt
H
H
D000914:Antibodies, Viral / Q000032:analysis*; D001782:Blood Donors; D001803:Blood Transfusion; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000276:immunology / Q000517:prevention & control; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007841:Latex Fixation Tests
D000914:Antibodies, Viral; D007074:Immunoglobulin G
CMV-Screening mit dem Latex-Agglutinationstest bei Blutspendern. Ein Vergleich zwischen EIA und Latex-Agglutination.